Seqera Labs is a bioinformatics company developing technologies for data pipelines, founded in 2018 in Barcelona.[1] It is a spin-off of the Centre for Genomic Regulation (CRG) founded by Evan Floden and Paolo di Tommaso and its services are largely related to the open-source software Nextflow, released in 2013.[1][2][3]

In 2022, the company raised 22 million euros in Series A funding.[4] It has also received several grants from the Chan Zuckerberg Initiative.[5]

References

  1. 1 2 Allen, Patricia (2022-10-25). "Barcelona-based Seqera Labs secures €22 million to help power innovation in healthcare and life sciences". EU-Startups. Retrieved 2023-03-30.
  2. ↑ Lunden, Ingrid (2021-09-07). "Seqera Labs grabs $5.5M to help sequence COVID-19 variants and other complex data problems". TechCrunch. Retrieved 2023-03-30.
  3. ↑ Kliver, Jenny. "CRG spin-off Seqera Labs raises 22 million euros in Series A funding – Barcelona Institute of Science and Technology – BIST". Retrieved 2023-03-30.
  4. ↑ "Addition leads Seqera Labs' €22 million investment round". Tech.eu. 2022-10-24. Retrieved 2023-03-30.
  5. ↑ "Mark Zuckerberg-backed Seqera Labs lands €22M as follow-on investment — TFN". Tech Funding News. 2022-10-25. Retrieved 2023-03-30.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.